Beginning Cash: The amount of cash reported by the company on its previous statement.
Windtree Therapeutics, Inc. (WINT) had Beginning Cash of $6.33M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-20.29M |
|
-- |
|
-- |
|
$20.60M |
|
$-20.60M |
|
$0.31M |
|
$-20.29M |
|
$-20.29M |
|
$-20.29M |
|
$-20.29M |
|
$-20.29M |
|
$-20.29M |
|
$-20.60M |
|
$-17.46M |
|
0.22M |
|
0.22M |
|
$-94.24 |
|
$-94.24 |
|
| Balance Sheet Financials | |
$5.38M |
|
$0.18M |
|
$27.03M |
|
$32.41M |
|
$4.00M |
|
$15.00M |
|
$25.02M |
|
$29.02M |
|
$3.39M |
|
$-21.86M |
|
$3.39M |
|
0.33M |
|
| Cash Flow Statement Financials | |
$-13.44M |
|
$-0.01M |
|
$11.60M |
|
|
Beginning Cash |
$6.33M |
$4.47M |
|
$-1.86M |
|
$1.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.35 |
|
-- |
|
-- |
|
0.82 |
|
4.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-598.38% |
|
92.83% |
|
-62.62% |
|
-110.33% |
|
$10.17 |
|
$-62.42 |
|
$-62.35 |
|